AbbVie Aktie

163,08USD -4,44USD -2,65%
AbbVie für 0 Euro bei ZERO ordern (zzgl. Spreads)
WKN DE: A1J84E / ISIN: US00287Y1091
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Aktionärsstruktur

Inhaber in %
Freefloat 99,89
The Vanguard Group, Inc. 9,08
Vanguard Group, Inc. (Subfiler) 8,63
State Street Corp. 4,43
Vanguard Total Stock Market ETF 3,14
BlackRock Fund Advisors 3,05
Capital Research & Management Co. (International Investors) 2,55
Vanguard 500 Index Fund 2,50
BlackRock Institutional Trust Co. NA 2,22
Geode Capital Management LLC 2,10
JPMorgan Investment Management, Inc. 1,92
Capital Research & Management Co. (Global Investors) 1,72
Charles Schwab Investment Management, Inc. 1,38
SPDR S&P 500 ETF Trust 1,21
Fidelity 500 Index Fund 1,20

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2019 2020 2021 2022 2023
Personal am Ende des Jahres 30 000 47 000 50 000 50 000 50 000
Umsatz pro Mitarbeiter in Mio. EUR 1,11 0,97 1,12 1,16 1,09

Bilanz (in Mio. EUR) - Aktiva

2019 2020 2021 2022 2023
Summe Umlaufvermögen 49 519 24 173 27 928 28 463 33 002
Summe Anlagevermögen 58 916 100 139 92 983 81 445 70 480
Summe Aktiva 89 115 150 565 146 529 138 805 134 711

Bilanz (in Mio. EUR) - Passiva

2019 2020 2021 2022 2023
Gesamtverschuldung/ -verbindlichkeiten 67 088 87 063 77 575 64 191 60 120
Summe Fremdkapital 97 287 137 468 131 093 121 518 124 314
Summe Eigenkapital -8 172 13 097 15 436 17 287 10 397
Summe Passiva 89 115 150 565 146 529 138 805 134 711

Adresse

1 North Waukegan Road, 60064-6400 North Chicago
Telefon +1 (847) 932-7900
Internet http://www.abbvie.com

Management

Azita Saleki-Gerhardt
Co-Chief Operations Officer & Executive VP
Brett J. Hart
Independent Director
Brian L. Durkin
Vice President
Carrie Strom
Senior VP & President-Global Allergan Aesthetics
Edward J. Rapp
Independent Director
Esteban Plata
Vice President-Western Europe & Canada
Frederick H. Waddell
Independent Director
Glenn Fletcher Tilton
Lead Independent Director
Jennifer L. Davis
Independent Director
Katherine Rielly-Gauvin
Vice President-Global Commercial Development
Kevin K. Buckbee
Senior Vice President & Controller
Liz Shea
Head-Investor Relations
Melody B. Meyer
Independent Non-Executive Director
Nicholas Donoghoe
Chief Business & Strategy Officer
Perry C. Siatis
Secretary, Executive VP & General Counsel
Rebecca Brown Roberts
Independent Director
Richard A. Gonzalez
Chairman & Chief Executive Officer
Robert A. Michael
President & Chief Operating Officer
Robert J. Alpern
Independent Director
Roopal Thakkar
Chief Medical Officer & SVP
Roxanne Schuh Austin
Independent Director
Scott T. Reents
Chief Financial Officer & Executive Vice President
Susan E. Quaggin
Independent Director
Thomas C. Freyman
Independent Director
Thomas J. Hudson
Chief Scientific Officer, Senior VP-R&D
Timothy J. Richmond
Chief Human Resources Officer & Executive VP
Todd D. Bosse
Vice President-Investor Relations
William H. L. Burnside
Independent Director